FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Axsome Therapeutics, Inc. AXSM announced that the FDA has accepted its resubmitted new drug application (NDA) seeking approval for AXS-07 for the acute treatment of migraine. A final decision from th...